Status:
RECRUITING
COMparative Performance of General Purpose Models
Lead Sponsor:
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Collaborating Sponsors:
University Medical Center Groningen
Conditions:
Neurosurgical Patients
Eligibility:
All Genders
Brief Summary
To compare the performance of the Eleveld models for propofol and remifentanil on neurosurgery patients admitted to intensive care with their intraoperative performance.
Detailed Description
Despite the widespread adoption of Target Controlled Infusion (TCI) models in modern clinical anesthesia practice, much less attention has been paid in the literature to their potential applications i...
Eligibility Criteria
Inclusion
- Adult patients undergoing elective neurosurgical procedures with an expected sedation after surgery of \> 12 hours • Requirement for an arterial line
Exclusion
- Pregnancy
- Known sensitivity or allergy to propofol or remifentanil
- Patient participating in research for which a period of exclusion is currently required by other study protocol, ethical committee or health authority.
- Age \< 18 years old
- Patients subjected to infusion of propofol and/or remifentanil not delivered through TCI pumps before the inclusion
- Patients exposed to other sedatives (benzodiazepines, volatile anesthetics, quetiapine) before the inclusion
Key Trial Info
Start Date :
October 2 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06584097
Start Date
October 2 2024
End Date
December 31 2026
Last Update
October 22 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Foundation IRCCS Carlo Besta Neurological Institute
Milan, Italy, Italy, 20133
2
Fondazione IRCCS Istituto Neurologico C. Besta
Milan, Milano, Italy, 20133